Global Age Related Macular Degeneration Drugs Supply, Demand and Key Producers, 2023-2029
Page: 97
Published Date: 31 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
This report studies the global Age Related Macular Degeneration Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Age Related Macular Degeneration Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Age Related Macular Degeneration Drugs that contribute to its increasing demand across many markets.
The global Age Related Macular Degeneration Drugs market size is expected to reach $ 11680 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
Highlights and key features of the study
Global Age Related Macular Degeneration Drugs total production and demand, 2018-2029, (K MT)
Global Age Related Macular Degeneration Drugs total production value, 2018-2029, (USD Million)
Global Age Related Macular Degeneration Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Age Related Macular Degeneration Drugs consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Age Related Macular Degeneration Drugs domestic production, consumption, key domestic manufacturers and share
Global Age Related Macular Degeneration Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Age Related Macular Degeneration Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Age Related Macular Degeneration Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT)
This reports profiles key players in the global Age Related Macular Degeneration Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bayer Healthcare, Roche, Neurotech Pharmaceuticals, Regeneron Pharmaceuticals and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Age Related Macular Degeneration Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Age Related Macular Degeneration Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Age Related Macular Degeneration Drugs Market, Segmentation by Type
Lucentis
Eylea
Avastin
Squalamine
Conercept
Lampalizamab
Others
Global Age Related Macular Degeneration Drugs Market, Segmentation by Application
50-60 Years Old
60-70 Years Old
Others
Companies Profiled:
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
Key Questions Answered
1. How big is the global Age Related Macular Degeneration Drugs market?
2. What is the demand of the global Age Related Macular Degeneration Drugs market?
3. What is the year over year growth of the global Age Related Macular Degeneration Drugs market?
4. What is the production and production value of the global Age Related Macular Degeneration Drugs market?
5. Who are the key producers in the global Age Related Macular Degeneration Drugs market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Age Related Macular Degeneration Drugs Introduction
1.2 World Age Related Macular Degeneration Drugs Supply & Forecast
1.2.1 World Age Related Macular Degeneration Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Age Related Macular Degeneration Drugs Production (2018-2029)
1.2.3 World Age Related Macular Degeneration Drugs Pricing Trends (2018-2029)
1.3 World Age Related Macular Degeneration Drugs Production by Region (Based on Production Site)
1.3.1 World Age Related Macular Degeneration Drugs Production Value by Region (2018-2029)
1.3.2 World Age Related Macular Degeneration Drugs Production by Region (2018-2029)
1.3.3 World Age Related Macular Degeneration Drugs Average Price by Region (2018-2029)
1.3.4 North America Age Related Macular Degeneration Drugs Production (2018-2029)
1.3.5 Europe Age Related Macular Degeneration Drugs Production (2018-2029)
1.3.6 China Age Related Macular Degeneration Drugs Production (2018-2029)
1.3.7 Japan Age Related Macular Degeneration Drugs Production (2018-2029)
1.3.8 Southeast Asia Age Related Macular Degeneration Drugs Production (2018-2029)
1.3.9 India Age Related Macular Degeneration Drugs Production (2018-2029)
1.3.10 Central & South America Age Related Macular Degeneration Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Age Related Macular Degeneration Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Age Related Macular Degeneration Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Age Related Macular Degeneration Drugs Demand (2018-2029)
2.2 World Age Related Macular Degeneration Drugs Consumption by Region
2.2.1 World Age Related Macular Degeneration Drugs Consumption by Region (2018-2023)
2.2.2 World Age Related Macular Degeneration Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Age Related Macular Degeneration Drugs Consumption (2018-2029)
2.4 China Age Related Macular Degeneration Drugs Consumption (2018-2029)
2.5 Europe Age Related Macular Degeneration Drugs Consumption (2018-2029)
2.6 Japan Age Related Macular Degeneration Drugs Consumption (2018-2029)
2.7 South Korea Age Related Macular Degeneration Drugs Consumption (2018-2029)
2.8 ASEAN Age Related Macular Degeneration Drugs Consumption (2018-2029)
2.9 India Age Related Macular Degeneration Drugs Consumption (2018-2029)
3.1 World Age Related Macular Degeneration Drugs Production Value by Manufacturer (2018-2023)
3.2 World Age Related Macular Degeneration Drugs Production by Manufacturer (2018-2023)
3.3 World Age Related Macular Degeneration Drugs Average Price by Manufacturer (2018-2023)
3.4 Age Related Macular Degeneration Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Age Related Macular Degeneration Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Age Related Macular Degeneration Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Age Related Macular Degeneration Drugs in 2022
3.6 Age Related Macular Degeneration Drugs Market: Overall Company Footprint Analysis
3.6.1 Age Related Macular Degeneration Drugs Market: Region Footprint
3.6.2 Age Related Macular Degeneration Drugs Market: Company Product Type Footprint
3.6.3 Age Related Macular Degeneration Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Age Related Macular Degeneration Drugs Production Value Comparison
4.1.1 United States VS China: Age Related Macular Degeneration Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Age Related Macular Degeneration Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Age Related Macular Degeneration Drugs Production Comparison
4.2.1 United States VS China: Age Related Macular Degeneration Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Age Related Macular Degeneration Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Age Related Macular Degeneration Drugs Consumption Comparison
4.3.1 United States VS China: Age Related Macular Degeneration Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Age Related Macular Degeneration Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Age Related Macular Degeneration Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Age Related Macular Degeneration Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Age Related Macular Degeneration Drugs Production (2018-2023)
4.5 China Based Age Related Macular Degeneration Drugs Manufacturers and Market Share
4.5.1 China Based Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Age Related Macular Degeneration Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Age Related Macular Degeneration Drugs Production (2018-2023)
4.6 Rest of World Based Age Related Macular Degeneration Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production (2018-2023)
5.1 World Age Related Macular Degeneration Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lucentis
5.2.2 Eylea
5.2.3 Avastin
5.2.4 Squalamine
5.2.5 Conercept
5.2.6 Lampalizamab
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Age Related Macular Degeneration Drugs Production by Type (2018-2029)
5.3.2 World Age Related Macular Degeneration Drugs Production Value by Type (2018-2029)
5.3.3 World Age Related Macular Degeneration Drugs Average Price by Type (2018-2029)
6.1 World Age Related Macular Degeneration Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 50-60 Years Old
6.2.2 60-70 Years Old
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Age Related Macular Degeneration Drugs Production by Application (2018-2029)
6.3.2 World Age Related Macular Degeneration Drugs Production Value by Application (2018-2029)
6.3.3 World Age Related Macular Degeneration Drugs Average Price by Application (2018-2029)
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Age Related Macular Degeneration Drugs Product and Services
7.1.4 Novartis Age Related Macular Degeneration Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Details
7.2.2 Bayer Healthcare Major Business
7.2.3 Bayer Healthcare Age Related Macular Degeneration Drugs Product and Services
7.2.4 Bayer Healthcare Age Related Macular Degeneration Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Healthcare Recent Developments/Updates
7.2.6 Bayer Healthcare Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Age Related Macular Degeneration Drugs Product and Services
7.3.4 Roche Age Related Macular Degeneration Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Details
7.4.2 Neurotech Pharmaceuticals Major Business
7.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Product and Services
7.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Neurotech Pharmaceuticals Recent Developments/Updates
7.4.6 Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Details
7.5.2 Regeneron Pharmaceuticals Major Business
7.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Product and Services
7.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.5.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Allergan
7.6.1 Allergan Details
7.6.2 Allergan Major Business
7.6.3 Allergan Age Related Macular Degeneration Drugs Product and Services
7.6.4 Allergan Age Related Macular Degeneration Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Allergan Recent Developments/Updates
7.6.6 Allergan Competitive Strengths & Weaknesses
8.1 Age Related Macular Degeneration Drugs Industry Chain
8.2 Age Related Macular Degeneration Drugs Upstream Analysis
8.2.1 Age Related Macular Degeneration Drugs Core Raw Materials
8.2.2 Main Manufacturers of Age Related Macular Degeneration Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Age Related Macular Degeneration Drugs Production Mode
8.6 Age Related Macular Degeneration Drugs Procurement Model
8.7 Age Related Macular Degeneration Drugs Industry Sales Model and Sales Channels
8.7.1 Age Related Macular Degeneration Drugs Sales Model
8.7.2 Age Related Macular Degeneration Drugs Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Age Related Macular Degeneration Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Age Related Macular Degeneration Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Age Related Macular Degeneration Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Age Related Macular Degeneration Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Age Related Macular Degeneration Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Age Related Macular Degeneration Drugs Production by Region (2018-2023) & (K MT)
Table 7. World Age Related Macular Degeneration Drugs Production by Region (2024-2029) & (K MT)
Table 8. World Age Related Macular Degeneration Drugs Production Market Share by Region (2018-2023)
Table 9. World Age Related Macular Degeneration Drugs Production Market Share by Region (2024-2029)
Table 10. World Age Related Macular Degeneration Drugs Average Price by Region (2018-2023) & (USD/MT)
Table 11. World Age Related Macular Degeneration Drugs Average Price by Region (2024-2029) & (USD/MT)
Table 12. Age Related Macular Degeneration Drugs Major Market Trends
Table 13. World Age Related Macular Degeneration Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K MT)
Table 14. World Age Related Macular Degeneration Drugs Consumption by Region (2018-2023) & (K MT)
Table 15. World Age Related Macular Degeneration Drugs Consumption Forecast by Region (2024-2029) & (K MT)
Table 16. World Age Related Macular Degeneration Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Age Related Macular Degeneration Drugs Producers in 2022
Table 18. World Age Related Macular Degeneration Drugs Production by Manufacturer (2018-2023) & (K MT)
Table 19. Production Market Share of Key Age Related Macular Degeneration Drugs Producers in 2022
Table 20. World Age Related Macular Degeneration Drugs Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 21. Global Age Related Macular Degeneration Drugs Company Evaluation Quadrant
Table 22. World Age Related Macular Degeneration Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Age Related Macular Degeneration Drugs Production Site of Key Manufacturer
Table 24. Age Related Macular Degeneration Drugs Market: Company Product Type Footprint
Table 25. Age Related Macular Degeneration Drugs Market: Company Product Application Footprint
Table 26. Age Related Macular Degeneration Drugs Competitive Factors
Table 27. Age Related Macular Degeneration Drugs New Entrant and Capacity Expansion Plans
Table 28. Age Related Macular Degeneration Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Age Related Macular Degeneration Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Age Related Macular Degeneration Drugs Production Comparison, (2018 & 2022 & 2029) & (K MT)
Table 31. United States VS China Age Related Macular Degeneration Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K MT)
Table 32. United States Based Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Age Related Macular Degeneration Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Age Related Macular Degeneration Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Age Related Macular Degeneration Drugs Production (2018-2023) & (K MT)
Table 36. United States Based Manufacturers Age Related Macular Degeneration Drugs Production Market Share (2018-2023)
Table 37. China Based Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Age Related Macular Degeneration Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Age Related Macular Degeneration Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Age Related Macular Degeneration Drugs Production (2018-2023) & (K MT)
Table 41. China Based Manufacturers Age Related Macular Degeneration Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Age Related Macular Degeneration Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production (2018-2023) & (K MT)
Table 46. Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production Market Share (2018-2023)
Table 47. World Age Related Macular Degeneration Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Age Related Macular Degeneration Drugs Production by Type (2018-2023) & (K MT)
Table 49. World Age Related Macular Degeneration Drugs Production by Type (2024-2029) & (K MT)
Table 50. World Age Related Macular Degeneration Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Age Related Macular Degeneration Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Age Related Macular Degeneration Drugs Average Price by Type (2018-2023) & (USD/MT)
Table 53. World Age Related Macular Degeneration Drugs Average Price by Type (2024-2029) & (USD/MT)
Table 54. World Age Related Macular Degeneration Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Age Related Macular Degeneration Drugs Production by Application (2018-2023) & (K MT)
Table 56. World Age Related Macular Degeneration Drugs Production by Application (2024-2029) & (K MT)
Table 57. World Age Related Macular Degeneration Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Age Related Macular Degeneration Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Age Related Macular Degeneration Drugs Average Price by Application (2018-2023) & (USD/MT)
Table 60. World Age Related Macular Degeneration Drugs Average Price by Application (2024-2029) & (USD/MT)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Age Related Macular Degeneration Drugs Product and Services
Table 64. Novartis Age Related Macular Degeneration Drugs Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Healthcare Major Business
Table 69. Bayer Healthcare Age Related Macular Degeneration Drugs Product and Services
Table 70. Bayer Healthcare Age Related Macular Degeneration Drugs Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Healthcare Recent Developments/Updates
Table 72. Bayer Healthcare Competitive Strengths & Weaknesses
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Age Related Macular Degeneration Drugs Product and Services
Table 76. Roche Age Related Macular Degeneration Drugs Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Roche Recent Developments/Updates
Table 78. Roche Competitive Strengths & Weaknesses
Table 79. Neurotech Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Neurotech Pharmaceuticals Major Business
Table 81. Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Product and Services
Table 82. Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Neurotech Pharmaceuticals Recent Developments/Updates
Table 84. Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Regeneron Pharmaceuticals Major Business
Table 87. Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Product and Services
Table 88. Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
Table 90. Allergan Basic Information, Manufacturing Base and Competitors
Table 91. Allergan Major Business
Table 92. Allergan Age Related Macular Degeneration Drugs Product and Services
Table 93. Allergan Age Related Macular Degeneration Drugs Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Global Key Players of Age Related Macular Degeneration Drugs Upstream (Raw Materials)
Table 95. Age Related Macular Degeneration Drugs Typical Customers
Table 96. Age Related Macular Degeneration Drugs Typical Distributors
List of Figure
Figure 1. Age Related Macular Degeneration Drugs Picture
Figure 2. World Age Related Macular Degeneration Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Age Related Macular Degeneration Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 5. World Age Related Macular Degeneration Drugs Average Price (2018-2029) & (USD/MT)
Figure 6. World Age Related Macular Degeneration Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Age Related Macular Degeneration Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 9. Europe Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 10. China Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 11. Japan Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 12. Southeast Asia Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 13. India Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 14. Central & South America Age Related Macular Degeneration Drugs Production (2018-2029) & (K MT)
Figure 15. Age Related Macular Degeneration Drugs Market Drivers
Figure 16. Factors Affecting Demand
Figure 17. World Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 18. World Age Related Macular Degeneration Drugs Consumption Market Share by Region (2018-2029)
Figure 19. United States Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 20. China Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 21. Europe Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 22. Japan Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 23. South Korea Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 24. ASEAN Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 25. India Age Related Macular Degeneration Drugs Consumption (2018-2029) & (K MT)
Figure 26. Producer Shipments of Age Related Macular Degeneration Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 27. Global Four-firm Concentration Ratios (CR4) for Age Related Macular Degeneration Drugs Markets in 2022
Figure 28. Global Four-firm Concentration Ratios (CR8) for Age Related Macular Degeneration Drugs Markets in 2022
Figure 29. United States VS China: Age Related Macular Degeneration Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 30. United States VS China: Age Related Macular Degeneration Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 31. United States VS China: Age Related Macular Degeneration Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 32. United States Based Manufacturers Age Related Macular Degeneration Drugs Production Market Share 2022
Figure 33. China Based Manufacturers Age Related Macular Degeneration Drugs Production Market Share 2022
Figure 34. Rest of World Based Manufacturers Age Related Macular Degeneration Drugs Production Market Share 2022
Figure 35. World Age Related Macular Degeneration Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 36. World Age Related Macular Degeneration Drugs Production Value Market Share by Type in 2022
Figure 37. Lucentis
Figure 38. Eylea
Figure 39. Avastin
Figure 40. Squalamine
Figure 41. Conercept
Figure 42. Lampalizamab
Figure 43. Others
Figure 44. World Age Related Macular Degeneration Drugs Production Market Share by Type (2018-2029)
Figure 45. World Age Related Macular Degeneration Drugs Production Value Market Share by Type (2018-2029)
Figure 46. World Age Related Macular Degeneration Drugs Average Price by Type (2018-2029) & (USD/MT)
Figure 47. World Age Related Macular Degeneration Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 48. World Age Related Macular Degeneration Drugs Production Value Market Share by Application in 2022
Figure 49. 50-60 Years Old
Figure 50. 60-70 Years Old
Figure 51. Others
Figure 52. World Age Related Macular Degeneration Drugs Production Market Share by Application (2018-2029)
Figure 53. World Age Related Macular Degeneration Drugs Production Value Market Share by Application (2018-2029)
Figure 54. World Age Related Macular Degeneration Drugs Average Price by Application (2018-2029) & (USD/MT)
Figure 55. Age Related Macular Degeneration Drugs Industry Chain
Figure 56. Age Related Macular Degeneration Drugs Procurement Model
Figure 57. Age Related Macular Degeneration Drugs Sales Model
Figure 58. Age Related Macular Degeneration Drugs Sales Channels, Direct Sales, and Distribution
Figure 59. Methodology
Figure 60. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis Bayer Healthcare Roche Neurotech Pharmaceuticals Regeneron Pharmaceuticals Allergan
Related Reports
15 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
